Phase I/II – Other

643 trials 280 recruiting

Filter these 643 trials by condition, country, sponsor and more.

Open in Search →

An open-label, phase I/II multicenter clinical trial of NECVAX-NEO1 as add-on to first-line neoadjuvant anti-PD-1 monoclonal antibody therap… Recruiting

2024-512520-11-00 Triple negative breast cancer (TNBC) 2024-11-19
mFBG PET-CT for neuroblastoma Recruiting

2022-501694-39-01 (suspision on) Neuroblastoma 2024-11-12
A study of AZD0901 alone or in combination with other anticancer drugs in patients with advanced/metastatic cancer. Recruiting

2023-508275-37-00 Gastric Cancer, Gastroesophageal Junction Cancer, Pancr 2024-11-11
Clinical trial with adipose tissue stem cells for the treatment of hidradenitis suppurativa. Recruiting

2024-516595-15-00 Hidradenitis suppurativa 2024-11-11
LIGHTBEAM-U01-Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Pa… Recruiting

2023-507178-41-00 Hematologic Malignancies or Solid Tumors in Pediatric a 2024-11-07
Phase I/II study assessing radioligand therapy (RLT) using 177Lu-PentixaTher for relapsed/refractory CXCR4+ acute leukemia. Recruiting

2022-501019-15-00 Acute Leukemia 2024-10-22
68Ga-FAPI-46 PET/CT for predicting histological response in triple-negative breast cancer Recruiting

2023-507860-37-00 Breast cancer 2024-10-14
A Phase 2a, dose-finding, randomized, double-blinded, placebo-controlled study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safet… Recruiting

2023-509613-37-01 Alzheimer's Disease 2024-10-08
A clinical imaging Study of the changes in [18F]F-AraG uptake following Radiotherapy in Non-small cell lung cancer. Recruiting

2024-517960-45-00 Melanoma 2024-10-02
A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Pouchitis 2024-09-27
Substudy 06D: Combination Therapies in 2L Advanced Gastroesophageal Adenocarcinoma Recruiting

2023-509306-29-00 Gastroesophageal cancer 2024-09-26
Substudy 06C: Combination Therapies in Gastroesophageal Adenocarcinoma Recruiting

2023-509307-33-00 Gastroesophageal cancer 2024-09-26
[68Ga]Ga-PentixaFor positron emission tomography for improved risk and disease assessment in myeloma Recruiting

2022-501811-14-00 Multiple Myeloma 2024-09-20
PREOPANC-5 Recruiting

2023-508707-20-00 Borderline resectable pancreatic cancer (BRPC) 2024-09-19
SAFETY AND POTENTIAL EFFECT OF INNOVATIVE CELL-BASED THERAPY USING ADIPOSE-DERIVED STROMAL VASCULAR FRACTION IN PATIENTS WITH AUTOIMMUNE XER… Recruiting

2023-505149-20-00 AUTOIMMUNE XEROSTOMIA 2024-09-13
A Phase I/II Study of Neoadjuvant, Intra-arterial Administration of [177Lu]Lu-PSMA-617 in Subjects with High-risk, Localised or Locally Adva… Recruiting

2022-500838-28-00 high-risk localized or locally advanced prostate cancer 2024-09-10
Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological ra… Recruiting

2024-515087-31-00 Breast cancer 2024-09-10
A clinical trial to be conducted in many hospitals and in different countries with the medicinal substance Regadenoson to be used in a type … Recruiting

2024-515244-22-00 Patients who need to undergo a clinically indicated pha 2024-09-09
Study in children and adolescents for the treatment of recurrent or relapsed solid tumours with the treatment of Lutathera® combined with ol… Recruiting

2024-512613-40-00 Recurrent or relapsed solid tumours expressing somatost 2024-08-28
MB-CART19.1 in refractory SLE Recruiting

2023-507654-33-00 Refractory systemic lupus erythematosus (SLE) 2024-08-12
A Trial to Learn if Linvoseltamab is Safe and Works in Adults with Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) Recruiting

2023-507809-34-00 Relapsed or Refractory Systemic Light Chain Amyloidosis 2024-08-07
A clinical study of MK-2870 alone or with other treatments to treat gastrointestinal cancers (MK-9999-02A) Recruiting

2023-508703-21-00 Colorectal cancer (CRC), pancreatic ductal adenocarcino 2024-08-01
A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR Cellular Therapies Recruiting

2024-512479-11-00 Solid Malignancy 2024-07-26
PHASE IB/II CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICACY OF CHEMOIMMUNOTHERAPY PLUS SHORT COURSE OF MEK INHIBITOR IN FIRST LINE OF TREA… Recruiting

2023-508477-87-00 Patients with localy advanced or metastatic non squamou 2024-07-24